Literature DB >> 21200102

The effects of endothelial dysfunction and inflammation on slow coronary flow.

Hasan Arı1, Selma Arı, Ercan Erdoğan, Osman Tiryakioğlu, Kağan Huysal, Vedat Koca, Tahsin Bozat.   

Abstract

OBJECTIVES: We evaluated the effects of endothelial dysfunction and inflammation on slow coronary flow (SCF). STUDY
DESIGN: The study included 26 patients (group 1; 13 females, 13 males; mean age 58.8 years) who had normal coronary arteries but SCF in three coronary vessels and 25 subjects (group 2, 14 females, 11 males; mean age 62.7 years) with normal coronary arteries and normal flow. Coronary flow was quantified according to the TIMI (Thrombolysis In Myocardial Infarction) frame count method for the left anterior descending (LAD), circumflex (Cx), and right coronary (RCA) arteries. Endothelial function was assessed by plasma asymmetric dimethylarginine (ADMA) levels, brachial artery endothelium-dependent flow-mediated dilatation (FMD), and nitroglycerin-mediated dilatation (NMD). Inflammation was assessed by high-sensitivity C-reactive protein (hs-CRP) levels.
RESULTS: TIMI frame count was significantly higher in group 1 compared to group 2 for each artery (p<0.001). In group 1, the mean FMD was significantly lower (6.6±1.6% vs. 11.2±1.6%, p<0.001) and the mean ADMA level was significantly higher (0.8±0.2 µmol/l vs. 0.5±0.1 µmol/l, p=0.002), whereas NMD and hs-CRP levels did not differ significantly between the two groups (p>0.05). There was a significant correlation between plasma ADMA level and TIMI frame count (RCA: r=0.50, p=0.001; cLAD: r=0.46, p=0.004; Cx: r=0.32, p=0.04) and a significant negative correlation between FMD and TIMI frame count (cLAD: r=-0.68, p=0.0003; Cx: r=-0.54, p=0.0004; RCA: r=-0.46, p=0.004), but hs-CRP level was not correlated with TIMI frame count. In multivariate analysis, only ADMA (p=0.009) and FMD (p=0.02) were significant parameters to predict SCF.
CONCLUSION: Our results suggest that endothelial dysfunction as determined by increased ADMA level and impaired FMD, rather than inflammation, plays a role in the etiopathogenesis of SCF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21200102

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  15 in total

1.  The association of serum albumin with coronary slow flow.

Authors:  Mustafa Cetin; Cemil Zencir; Hakan Tasolar; Erkan Baysal; Mehmet Balli; Erdal Akturk
Journal:  Wien Klin Wochenschr       Date:  2014-07-01       Impact factor: 1.704

2.  Assessment of risk factors and left ventricular function in patients with slow coronary flow.

Authors:  Yuling Li; Yonghuai Wang; Dalin Jia; Yan Lv; Yan Zhang; Zhengyu Guan; Chunyan Ma
Journal:  Heart Vessels       Date:  2014-12-05       Impact factor: 2.037

3.  Increased serum resistin levels in patients with coronary slow-flow phenomenon.

Authors:  A Canga; M Cetin; S A Kocaman; M E Durakoğlugil; A Kırbaş; T Erdoğan; A Temiz; A Yılmaz; Y Ciçek
Journal:  Herz       Date:  2013-02-13       Impact factor: 1.443

4.  Coronary artery ectasia in Crohn's disease.

Authors:  Theofanis Korovesis; George Katritsis; Panagiotis Koudounis; Theodoros Zografos
Journal:  BMJ Case Rep       Date:  2018-10-21

5.  Predictors of slow flow in angiographically normal coronary arteries.

Authors:  Ibrahim Altun; Fatih Akin; Nuri Kose; Cem Sahin; Ismail Kirli
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Endothelial nitric oxide synthase levels and their response to exercise in patients with slow coronary flow.

Authors:  Hakan Taşolar; Ferhat Eyyüpkoca; Erdal Aktürk; Yasin Karakuş; Mehmet Cansel; Jülide Yağmur; Fatma Ozyalin; Burak Altun; Hasan Pekdemir
Journal:  Cardiovasc J Afr       Date:  2013 Oct-Nov       Impact factor: 1.167

Review 7.  Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies.

Authors:  Sabrina Schlesinger; Svenja R Sonntag; Wolfgang Lieb; Renke Maas
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

8.  Relationship between platelet-to-lymphocyte ratio and coronary slow flow.

Authors:  Muhammed Oylumlu; Adnan Doğan; Mustafa Oylumlu; Abdülkadir Yıldız; Murat Yüksel; Fethullah Kayan; Celal Kilit; Basri Amasyalı
Journal:  Anatol J Cardiol       Date:  2014-04-08       Impact factor: 1.596

9.  Could neutrophil/lymphocyte ratio be an indicator of coronary artery disease, coronary artery ectasia and coronary slow flow?

Authors:  Mücahid Yılmaz; Hasan Korkmaz; Mehmet Nail Bilen; Ökkeş Uku; Ertuğrul Kurtoğlu
Journal:  J Int Med Res       Date:  2016-11-10       Impact factor: 1.671

10.  Endothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow.

Authors:  Emine Gazi; Ahmet Temiz; Burak Altun; Ahmet Barutcu; Fatma Silan; Yucel Colkesen; Ozturk Ozdemir
Journal:  Cardiovasc J Afr       Date:  2014-01-17       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.